Cantel Medical (NYSE:CMN) said today it closed its $13.5 million buy of North American Science Associates sterility assurance business, which Cantel said it plans to fold into its Crosstex division.
The NAMSA operation, which posted sales of $5.7 million last year, makes biological and chemical indicators designed to monitor the effectiveness of sterilization procedures.
Little Falls, N.J.-based Cantel Medical said the sterility assurance monitoring business manufactures biological and chemical indicators used to monitor the effectiveness of sterilization processes, designed primarily for the industrial segment serving medical devices, life sciences and other manufacturers.
The acquisition was originally announced in early February, and calls for NAMSA to continue making the products until the middle of 2016, when they’re slated to be integrated into Crosstex’s manufacturing chain, Northwood, Ohio-based NAMSA said.
Little Falls, N.J.-based Cantel said it doesn’t expect the deal to add much to earnings until fiscal 2017.
The post Cantel Medical closes $13.5m buy of NAMSA’s sterility assurance biz appeared first on MassDevice.
from MassDevice http://ift.tt/1ToDzT2
Cap comentari:
Publica un comentari a l'entrada